MLAB Key Statistics, Chart & Performance
The current stock price of MLAB is 78.5 USD. In the past month the price increased by 3.21%. In the past year, price decreased by -43.26%.
MLAB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.87 | 217.71B | ||
| DHR | DANAHER CORP | 29.69 | 161.70B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 183 | 55.61B | ||
| A | AGILENT TECHNOLOGIES INC | 24.39 | 38.58B | ||
| IQV | IQVIA HOLDINGS INC | 19.38 | 38.39B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 33.32 | 28.48B | ||
| WAT | WATERS CORP | 29.91 | 22.61B | ||
| ILMN | ILLUMINA INC | 30.08 | 20.04B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.92 | 19.79B | ||
| MEDP | MEDPACE HOLDINGS INC | 39.28 | 15.82B | ||
| RVTY | REVVITY INC | 20.2 | 10.97B | ||
| TEM | TEMPUS AI INC | N/A | 10.51B |
Related stock screener links
About MLAB
Company Profile
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 730 full-time employees. The firm's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Company Info
MESA LABORATORIES INC
12100 W 6th Ave
Lakewood COLORADO 80228 US
CEO: Gary M. Owens
Employees: 730
Phone: 13039878000
MESA LABORATORIES INC / MLAB FAQ
Can you describe the business of MESA LABORATORIES INC?
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 730 full-time employees. The firm's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
What is the stock price of MESA LABORATORIES INC today?
The current stock price of MLAB is 78.5 USD. The price decreased by -0.13% in the last trading session.
Does MESA LABORATORIES INC pay dividends?
MESA LABORATORIES INC (MLAB) has a dividend yield of 0.79%. The yearly dividend amount is currently 0.64.
What is the ChartMill rating of MESA LABORATORIES INC stock?
MLAB has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the sector and industry classification for MESA LABORATORIES INC?
MESA LABORATORIES INC (MLAB) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Is MESA LABORATORIES INC (MLAB) expected to grow?
The Revenue of MESA LABORATORIES INC (MLAB) is expected to grow by 3.09% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for MESA LABORATORIES INC?
MESA LABORATORIES INC (MLAB) has a market capitalization of 433.32M USD. This makes MLAB a Small Cap stock.
MLAB Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to MLAB. When comparing the yearly performance of all stocks, MLAB is a bad performer in the overall market: 81.73% of all stocks are doing better.
MLAB Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MLAB. There are concerns on the financial health of MLAB while its profitability can be described as average.
MLAB Financial Highlights
Over the last trailing twelve months MLAB reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS decreased by -104.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.37% | ||
| ROE | -0.88% | ||
| Debt/Equity | 0.95 |
MLAB Forecast & Estimates
9 analysts have analysed MLAB and the average price target is 96.9 USD. This implies a price increase of 23.44% is expected in the next year compared to the current price of 78.5.
For the next year, analysts expect an EPS growth of 2707.43% and a revenue growth 3.09% for MLAB